RE:RE:RE:RE:RE:For those of youRumpl3StiltSkin wrote: I have to say FGP, Big is probably correct. PDCs are less drug, more of a technology that works at the cellular level. So in theory, in perfect conditions it could work at a very high %. Perhaps not as high as the pietrie dish ideal? But still there are some folks that still have bladders. Now time to get at solid tumors and how to activate them deep.
Rumpl3StiltSkin, good post...
Here is a little reminder.
Laboratory rats are rats that have been grow with a specific cancer(bladder).
But there is a very good reason why the high CR% in rats is never reproduce in human.
-The rats are not a 70 to 90 years old patients.
-The rats are not immuno-deficient like older patients.
-The rats are not type11 diabetics.
-The rats do not have all kind of health problems(like an 80 years old patients).
In short.. the rats are not end of the line patients.
If TLT was treating a patient with only a bladder cancer(like the laboratory rats) the CR% would be very high(over 85% is a good guess).
That is why when TLT will be permitted to treat patients earlier(like BCG), TLT could have a very big CR% with no side effects.
Big Pharma know this.